Sonoma Pharmaceuticals Announces Termination of Executive Vice President
I'm PortAI, I can summarize articles.
On October 18, 2025, Sonoma Pharmaceuticals, Inc. announced the immediate termination of Bruce Thornton as Executive Vice President and Chief Operating Officer for cause, as per his employment agreement. Replacement information has not been disclosed. This announcement was filed with the SEC under the original filing number SNOA - 8-K on October 23, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments